Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Gains from Investment Securities: 2020-2024

Historic Gains from Investment Securities for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to -$619000.0.

  • Oncology Institute's Gains from Investment Securities rose 85000.0% to $150000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $299000.0, marking a year-over-year increase of 12632.04%. This contributed to the annual value of -$619000.0 for FY2024, which is 2291.41% up from last year.
  • Latest data reveals that Oncology Institute reported Gains from Investment Securities of -$619000.0 as of FY2024, which was up 2291.41% from -$803000.0 recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Gains from Investment Securities peaked at $207000.0 during FY2020, and registered a low of -$59.2 million during FY2022.
  • Its 5-year average for Gains from Investment Securities is -$17.1 million, with a median of -$803000.0 in 2023.
  • Per our database at Business Quant, Oncology Institute's Gains from Investment Securities crashed by 1212463.77% in 2021 and then skyrocketed by 9864.39% in 2023.
  • Over the past 5 years, Oncology Institute's Gains from Investment Securities (Annual) stood at $207000.0 in 2020, then crashed by 12124.64% to -$24.9 million in 2021, then plummeted by 137.9% to -$59.2 million in 2022, then skyrocketed by 98.64% to -$803000.0 in 2023, then grew by 22.91% to -$619000.0 in 2024.
  • Its Gains from Investment Securities was -$619000.0 in FY2024, compared to -$803000.0 in FY2023 and -$59.2 million in FY2022.